搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
The Pharma Letter
2 小时
Shaping the future: how cultural transformation fuels digital innovation in UK pharma
A century later, that sentiment is as pertinent as ever. Artificial Intelligence (AI) is being incorporated into a myriad of ...
The Pharma Letter
2 小时
OmniaBio opens largest advanced therapy facility
OmniaBio, a subsidiary of Canada's Centre for Commercialization of Regenerative Medicine, has opened a 120,000-square-foot ...
The Pharma Letter
2 小时
Merger to create global Treg company
Taiwan-based REGiMMUNE, a biopharma creating immunotherapies through the power of regulatory T cells (Tregs), and ...
The Pharma Letter
2 小时
LaNova Medicines secures $41 million in series C round
Shanghai-based biopharma LaNova Medicines has raised 3 billion yuan ($41 million) in a series C round led by China ...
The Pharma Letter
19 小时
FDA puts partial clinical hold on gotistobart trial
The US Food and Drug Administration (FDA) has placed a partial clinical hold on the two-stage, open-label, randomized Phase ...
The Pharma Letter
5 小时
Coalition of EU groups call for bold and open trade policy
As the European Parliament prepares for the confirmation hearings of the new Commissioners, the Open Trade Coalition is ...
The Pharma Letter
19 小时
October 2024 EMA/CHMP batch of positive opinions
The European Medicines Agency’s (EMA) human health committee, CHMP, announced six positive opinions of novel medicines, as ...
The Pharma Letter
6 小时
FDA finally approves Vyalev for Parkinson’s disease
After a couple of negative decisions, the US Food and Drug Administration (FDA) has approved Vyalev (foscarbidopa and ...
The Pharma Letter
6 小时
Lexicon pens licensing deal with Viatris for sotagliflozin
Texas, USA-based Lexicon Pharmaceuticals announced that Viatris has obtained an exclusive license from Lexicon to ...
The Pharma Letter
9 小时
BenevolentAI founder returns as executive chairman amid leadership overhaul
British AI drug discovery firm BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. His ...
The Pharma Letter
9 小时
Terray Therapeutics closes $120 million financing
California, USA-based biotech Terray Therapeutics, yesterday announced the closing of an oversubscribed Series B funding of ...
The Pharma Letter
20 小时
FDA slaps clinical hold on Novavax' COVID-19 flu combo trial IND
Shares of US protein-based vaccine maker Novavax closed down 19.4% at $10.15 yesterday having dropped as much as 24%, on the ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈